Clinical Trial Update: Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating intravenous treprostinil (Remodulin) for pulmonary arterial hypertension in India was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Remodulin (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: TERMINATED